2019
DOI: 10.4103/idoj.idoj_475_18
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Trial Designs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 84 publications
(38 citation statements)
references
References 20 publications
0
33
0
Order By: Relevance
“…Furthermore, the effects of prolonged use of a “sham” type of ILF-Neurofeedback should be verified to avoid possible iatrogenic effects on participants. For these reasons, an active concurrent control design (as in Balt et al, 2020 ) should be considered whenever possible, as proposed by the Declaration of Helsinki (World Medical Association, 2018 ; Nair, 2019 ).…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, the effects of prolonged use of a “sham” type of ILF-Neurofeedback should be verified to avoid possible iatrogenic effects on participants. For these reasons, an active concurrent control design (as in Balt et al, 2020 ) should be considered whenever possible, as proposed by the Declaration of Helsinki (World Medical Association, 2018 ; Nair, 2019 ).…”
Section: Resultsmentioning
confidence: 99%
“…An outcome of interest is then compared between these groups and estimates the impact of the intervention. The clinical trials may be classified into different types ( 12 , 13 ), namely, parallel, crossover and factorial designs (see Table 2 ), depending on the objective of the study and the population studied.…”
Section: Selecting the Appropriate Study Designmentioning
confidence: 99%
“…Following the randomization procedure, each participant will remain in his or her assigned treatment arm for the duration of the study. This design is the simplest and allows two or more therapies to be compared simultaneously [30]. An example of this type of design in nutrition was carried out by Hussey and Klein in 1990; through a parallel design RCT, they compared the effect of vitamin A administration against placebo, concluding that vitamin A reduces mortality caused by measles in minors [31].…”
Section: Parallel Designmentioning
confidence: 99%
“…The first is that the disease or condition being studied must be chronic and stable, and the characteristics must not change between the two study periods. The second criterion that must be met is that the intervention's effects must not be irreversible, and changes should preferably be visible in a short period of time [30]. In the case of the DASH diet, both criteria are met; hypertension is a chronic and stable disease, and the intervention does not result in permanent changes, that is, a patient with hypertension can lower his blood pressure while adhering to a specific nutritional plan, but his blood pressure may rise again after quitting or adopting harmful habits.…”
Section: Crossover Designmentioning
confidence: 99%